1-2 of 2
Elizabeth Eisenhauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase II trial of a second generation antisense oligonucleotide (ASO) to clusterin (OGX-011) in combination with docetaxel in metastatic breast cancer (MBC): NCIC-CTG IND 164 trial.

Free
Stephen Chia, Susan Dent, Susan Ellard, Peter Ellis, Ted Vandenberg, Karen Gelmon, Jean Powers, Lesley Seymour, Elizabeth Eisenhauer
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3512.
Published: 01 May 2007
View articletitled, A phase II trial of a second generation antisense oligonucleotide (ASO) to clusterin (OGX-011) in combination with docetaxel in metastatic breast cancer (MBC): NCIC-CTG IND 164 trial.
Journal Articles

Phase I Pharmacokinetic and Pharmacodynamic Study of a New Anthrapyrazole, CI-937 (DUP937)

Free
Charles Erlichman, Malcolm Moore, Ian G. Kerr, Bradley Wong, Elizabeth Eisenhauer, Benny Zee, Lloyd R. Whitfield
Journal: Cancer Research
Cancer Res (1991) 51 (23_Part_1): 6317–6322.
Published: 12 January 1991
View articletitled, Phase I Pharmacokinetic and Pharmacodynamic Study of a New Anthrapyrazole, CI-937 (DUP937)
Open the PDF for Phase I Pharmacokinetic and Pharmacodynamic Study of a New Anthrapyrazole, CI-937 (DUP937) in another window